AI-generated summary
This review assesses intense pulsed light (IPL) for meibomian gland dysfunction, an eye disorder. The authors report that recent randomized trials found IPL improved gland function, tear film quality and dry eye symptoms, though the mechanism remains unclear. They describe IPL as potentially well tolerated and effective, while noting concerns about long-term efficacy, accessibility and cost.
- Who or what was studied
- Patients with meibomian gland dysfunction (MGD)
- Limits stated in the abstract
- The abstract states the mechanism of action is unclear, long-term efficacy is uncertain, and cost and accessibility are drawbacks.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on journals.lww.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a review: what to check before relying on this kind of research.
Terms in this paper: Dry eye. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.